Outcome of fetuses with increased nuchal translucency

被引:16
作者
Bilardo, CM [1 ]
Müller, MA [1 ]
Pajkrt, E [1 ]
机构
[1] Acad Med Ctr, Dept Obstet & Gynaecol, NL-1100 DE Amsterdam, Netherlands
关键词
D O I
10.1097/00001703-200104000-00012
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Recent reports on nuchal translucency screening in unselected patient populations show results that are comparable with those reported by the thus far largest series on screening for Down's syndrome based on maternal age acid nuchal translucency measurement. Much interest is focused on the prognostic value of increased nuchal translucency in fetuses with normal chromosomes. Increased nuchal translucency is regarded as a clear sign of declining fetal health, which can be associated with fetal demise, structural anomalies, rare genetic syndromes, and in particular congenital heart defects. A clear association is demonstrated between nuchal translucency above the 99th centile and congenital cardiac defects, Such a finding should prompt specialized echocardiography. However, on the whole the sensitivity of nuchal translucency screening is too low to consider this as the sole criterion to screen for critical heart defects, Curr Opin Obstet Gynecol 13:169-174. (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:169 / 174
页数:6
相关论文
共 69 条
[1]  
Achiron R, 2000, AM J MED GENET, V92, P159, DOI 10.1002/(SICI)1096-8628(20000529)92:3<159::AID-AJMG1>3.0.CO
[2]  
2-2
[3]   Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population [J].
Adekunle, O ;
Gopee, A ;
El-Sayed, M ;
Thilaganathan, B .
BRITISH JOURNAL OF RADIOLOGY, 1999, 72 (857) :457-460
[4]   FAMILIAL RECURRENCE OF CONGENITAL HEART-DISEASE IN A PROSPECTIVE SERIES OF MOTHERS REFERRED FOR FETAL ECHOCARDIOGRAPHY [J].
ALLAN, LD ;
CRAWFORD, DC ;
CHITA, SK ;
ANDERSON, RH ;
TYNAN, MJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1986, 58 (03) :334-337
[5]   Nuchal thickness, urine β-core fragment level, and maternal age for Down syndrome screening [J].
Bahado-Singh, RO ;
Oz, AU ;
Flores, D ;
Cermik, D ;
Acuna, E ;
Mahoney, MJ ;
Cole, L .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (02) :491-495
[6]   Efficiency of ultrasound and biochemical markers for Down's syndrome risk screening - A prospective study [J].
Benattar, C ;
Audibert, F ;
Taieb, J ;
Ville, Y ;
Roberto, A ;
Lindenbaum, A ;
Frydman, R .
FETAL DIAGNOSIS AND THERAPY, 1999, 14 (02) :112-117
[7]  
Berger A, 1999, BRIT MED J, V318, P85
[8]   Outcome of fetuses with enlarged nuchal translucency and normal karyotype [J].
Bilardo, CM ;
Pajkrt, E ;
de Graaf, I ;
Mol, BW ;
Bleker, OP .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1998, 11 (06) :401-406
[9]   Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK [J].
Bull, C .
LANCET, 1999, 354 (9186) :1242-1247
[10]   First-trimester transabdominal fetal echocardiography [J].
Carvalho, JS ;
Moscoso, G ;
Ville, Y .
LANCET, 1998, 351 (9108) :1023-1027